DEFR14A: Vivani Medical Files Amended Proxy Statement, Corrects Errors and Sets Meeting Date

Vivani Medical amends its definitive proxy statement to correct scrivener's errors in dates and compensation information, setting the Annual Meeting for June 24, 2025.

Summary

• Vivani Medical, Inc. filed an amendment to its definitive proxy statement to correct errors related to certain dates and compensation information.
• The amendment clarifies the date of the Annual Meeting of Stockholders, which is set for June 24, 2025, at 10:00 a.m. Pacific Time, to be held entirely online.
• The record date for the Annual Meeting is April 25, 2025.
• The amendment also corrects the total compensation paid to director Gregg Williams for the fiscal year 2024, which is now stated as $105,667.
• The proxy statement includes proposals for the election of six directors, ratification of the appointment of BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and a non-binding advisory vote on executive compensation.
• The board of directors recommends voting FOR all proposals.
• The company had 59,243,903 shares of common stock outstanding and entitled to vote as of the Record Date.
• The proxy statement details the procedures for voting, attending the virtual Annual Meeting, and submitting questions.
• The company is using the internet as the primary means of providing proxy materials to stockholders.
• The company's board of directors has adopted a Compensation Recovery Policy effective as of August 11, 2023, which requires recovery from executive officers of incentive-based compensation that is earned, granted or vested based on the achievement of a financial reporting measure in the event of a required accounting restatement of previously issued financial statements.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, with a neutral to slightly positive sentiment due to the company's efforts to correct errors and engage with stockholders. The capital raise is a positive sign.

Positives

• The company is taking steps to ensure accurate information is provided to stockholders by correcting errors in the proxy statement.
• The use of a virtual Annual Meeting format allows for broader participation from stockholders.
• The company has a Compensation Recovery Policy in place.

Negatives

• The need to amend the proxy statement indicates initial errors in the provided information.
• The company reported a net loss of ($23,486,000) in 2024.

Risks

• The company's future success depends on attracting and retaining qualified personnel.
• The company's stock price performance may impact executive compensation and stockholder returns.
• The company's financial performance may be affected by various risks and exposures associated with strategic, financial, and execution risks.

Future Outlook

The proxy statement outlines proposals for the upcoming Annual Meeting, including the election of directors and ratification of the independent auditor, indicating a focus on corporate governance and financial oversight.

Management Comments

• Adam Mendelsohn, Chief Executive Officer, invites stockholders to attend the Annual Meeting and emphasizes the importance of their vote.
• The Board of Directors recommends voting FOR all proposals.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including proxy solicitations, director elections, and auditor ratification. The focus on executive compensation and related party transactions aligns with increased scrutiny on corporate governance in the current market environment.

Comparison to Industry Standards

• The structure and content of the proxy statement are consistent with SEC regulations and industry best practices.
• The use of independent directors on key committees aligns with Nasdaq listing requirements and corporate governance standards.
• The disclosure of related party transactions and executive compensation is in line with regulatory expectations for transparency.
• The company's compensation recovery policy is in line with Nasdaq listing rules.

Related Party Transactions

• On November 8, 2024, Vivani Medical sold 3,968,253 shares of Common Stock to Gregg Williams, an independent director, at $1.26 per share, resulting in gross proceeds of approximately $5 million.
• Effective March 26, 2025, Vivani Medical entered into a share purchase agreement with an entity beneficially owned by Gregg Williams for 7,366,071 shares of Common Stock at $1.12 per share, expected to result in gross proceeds of approximately $8.25 million by January 15, 2026.

Stakeholder Impact

• Stockholders have the opportunity to influence the direction of the company through their votes on key proposals.
• Employees are indirectly affected by the decisions made at the Annual Meeting, particularly regarding executive compensation and corporate governance.
• The company's financial performance and strategic direction impact its stakeholders, including customers, suppliers, and creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The Annual Meeting will be held on June 24, 2025, where the results of the votes will be announced.
• The company will continue to operate under the direction of the elected directors and with the ratified independent auditor.

Key Dates

Keywords

proxy statement, annual meeting, directors, executive compensation, BPM LLP, stockholders, voting, Vivani Medical